Beth Ziegler - Concepedia

Author

Beth Ziegler

Also Known As

Beth Ziegler

Publications

190

Citations

H-Index

Concepts

All Affiliations

Beth Ziegler is an author at Amgen (United States) specializing in medicine, radiation oncology, and tumor biology.

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	162
2	Pharmacology	2	2	162
3	Natural Sciences	1	1	44
4	Biochemistry	1	1	44
5	Cell Biology	1	1	118

Beth Ziegler

Publications

186

Citations

H-Index

Page 1

	Year	Citations
Preclinical Evaluation of AMG 900, a Novel Potent and Highly Selective Pan-Aurora Kinase Inhibitor with Activity in Taxane-Resistant Tumor Cell Lines Marc Payton, Tammy L. Bush, Grace Chung, Cancer Research Cell DeathNovel PotentCancer BiologyGliomaTumor Biology	2010	118
Discovery of <i>N</i>-(4-(3-(2-Aminopyrimidin-4-yl)pyridin-2-yloxy)phenyl)-4-(4-methylthiophen-2-yl)phthalazin-1-amine (AMG 900), A Highly Selective, Orally Bioavailable Inhibitor of Aurora Kinases with Activity against Multidrug-Resistant Cancer Cell Lines Stephanie Geuns-Meyer, Victor J. Cee, Holly L. Deak, Journal of Medicinal Chemistry PharmacotherapyPharmaceutical ChemistryTumor BiologyPhysical PropertiesMolecular Pharmacology	2015	44
Antitumor activity of motesanib alone and in combination with cisplatin or docetaxel in multiple human non–small-cell lung cancer xenograft models Angela Coxon, Beth Ziegler, Stephen A. Kaufman, Molecular Cancer	2012	24

Page 1